Copyright
©2010 Baishideng.
World J Hepatol. Mar 27, 2010; 2(3): 103-113
Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.103
Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.103
Figure 1 Schematic representation of HCC carcinogenesis.
Figure 2 Molecularly targeted agents of potential interest in HCC and relative targets.
A: EGFR and VEGF/VEGFR pathways; B: The MAP-kinase and PI3K/mTOR pathways.
- Citation: Porta C, Paglino C. Medical treatment of unresectable hepatocellular carcinoma: Going beyond sorafenib. World J Hepatol 2010; 2(3): 103-113
- URL: https://www.wjgnet.com/1948-5182/full/v2/i3/103.htm
- DOI: https://dx.doi.org/10.4254/wjh.v2.i3.103